 | • レポートコード：QAF27568 • 出版社/出版日：QYResearch / 2021年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の抗菌ペプチド市場について種類別（植物抗菌ペプチド、微生物抗菌ペプチド、動物抗菌ペプチド）、用途別（医薬品、飼料添加物、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗菌ペプチド市場の概要 ・世界の主要地域別抗菌ペプチド市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の抗菌ペプチド市場規模2016-2021：種類別（植物抗菌ペプチド、微生物抗菌ペプチド、動物抗菌ペプチド） ・世界の抗菌ペプチド市場予測2012-2027：種類別（植物抗菌ペプチド、微生物抗菌ペプチド、動物抗菌ペプチド） ・世界の抗菌ペプチド市場規模2016-2021：用途別（医薬品、飼料添加物、その他） ・世界の抗菌ペプチド市場予測2012-2027：用途別（医薬品、飼料添加物、その他） ・抗菌ペプチドのアメリカ市場規模と予測2016-2021 ・抗菌ペプチドのヨーロッパ市場規模と予測2016-2021 ・抗菌ペプチドの中国市場規模と予測2016-2021 ・抗菌ペプチドの日本市場規模と予測2016-2021 ・抗菌ペプチドの東南アジア市場規模と予測2016-2021 ・抗菌ペプチドのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AnaSpec、AMP Biotech、Phoenix Biotech、Novabiotics、Chinese Peptide、Ontores、GenScript、Hycult Biotech、Sunsmile、Ruixing Biotechnology、Zhongnong Yingtai Biotechnology、Glam Technology、ProteLight Pharmaceutical & Biotechnology） ・抗菌ペプチドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗菌ペプチドの市場動向・機会・課題 ・調査の結論 |
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
Market Analysis and Insights: Global Antimicrobial Peptides Market
The global Antimicrobial Peptides market was valued at US$ 5 in 2020 and will reach US$ 6 million by the end of 2027, growing at a CAGR of 5.4% during 2022-2027.
Global Antimicrobial Peptides Scope and Market Size
The global Antimicrobial Peptides market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antimicrobial Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
Segment by Application
Pharmaceuticals
Feed Additives
Others
The Antimicrobial Peptides market is analysed and market size information is provided by regions (countries). Segment by Application, the Antimicrobial Peptides market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
1 Antimicrobial Peptides Market Overview
1.1 Antimicrobial Peptides Product Scope
1.2 Antimicrobial Peptides Segment by Type
1.2.1 Global Antimicrobial Peptides Sales by Type (2016 & 2021 & 2027)
1.2.2 Plant Antimicrobial Peptides
1.2.3 Microbial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Antimicrobial Peptides Segment by Application
1.3.1 Global Antimicrobial Peptides Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Antimicrobial Peptides Market Estimates and Forecasts (2016-2027)
1.4.1 Global Antimicrobial Peptides Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Antimicrobial Peptides Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Antimicrobial Peptides Price Trends (2016-2027)
2 Antimicrobial Peptides Estimates and Forecasts by Region
2.1 Global Antimicrobial Peptides Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Antimicrobial Peptides Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Antimicrobial Peptides Sales Market Share by Region (2016-2021)
2.2.2 Global Antimicrobial Peptides Revenue Market Share by Region (2016-2021)
2.3 Global Antimicrobial Peptides Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Antimicrobial Peptides Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Antimicrobial Peptides Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Antimicrobial Peptides Estimates and Projections (2016-2027)
2.4.2 Europe Antimicrobial Peptides Estimates and Projections (2016-2027)
2.4.3 China Antimicrobial Peptides Estimates and Projections (2016-2027)
2.4.4 Japan Antimicrobial Peptides Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Antimicrobial Peptides Estimates and Projections (2016-2027)
2.4.6 India Antimicrobial Peptides Estimates and Projections (2016-2027)
3 Global Antimicrobial Peptides Competition Landscape by Players
3.1 Global Top Antimicrobial Peptides Players by Sales (2016-2021)
3.2 Global Top Antimicrobial Peptides Players by Revenue (2016-2021)
3.3 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2020)
3.4 Global Antimicrobial Peptides Average Price by Company (2016-2021)
3.5 Manufacturers Antimicrobial Peptides Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Antimicrobial Peptides Market Size by Type
4.1 Global Antimicrobial Peptides Historic Market Review by Type (2016-2021)
4.1.1 Global Antimicrobial Peptides Sales Market Share by Type (2016-2021)
4.1.2 Global Antimicrobial Peptides Revenue Market Share by Type (2016-2021)
4.1.3 Global Antimicrobial Peptides Price by Type (2016-2021)
4.2 Global Antimicrobial Peptides Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antimicrobial Peptides Sales Forecast by Type (2022-2027)
4.2.2 Global Antimicrobial Peptides Revenue Forecast by Type (2022-2027)
4.2.3 Global Antimicrobial Peptides Price Forecast by Type (2022-2027)
5 Global Antimicrobial Peptides Market Size by Application
5.1 Global Antimicrobial Peptides Historic Market Review by Application (2016-2021)
5.1.1 Global Antimicrobial Peptides Sales Market Share by Application (2016-2021)
5.1.2 Global Antimicrobial Peptides Revenue Market Share by Application (2016-2021)
5.1.3 Global Antimicrobial Peptides Price by Application (2016-2021)
5.2 Global Antimicrobial Peptides Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antimicrobial Peptides Sales Forecast by Application (2022-2027)
5.2.2 Global Antimicrobial Peptides Revenue Forecast by Application (2022-2027)
5.2.3 Global Antimicrobial Peptides Price Forecast by Application (2022-2027)
6 North America Antimicrobial Peptides Market Facts & Figures
6.1 North America Antimicrobial Peptides Sales by Company
6.1.1 North America Antimicrobial Peptides Sales by Company (2016-2021)
6.1.2 North America Antimicrobial Peptides Revenue by Company (2016-2021)
6.2 North America Antimicrobial Peptides Sales Breakdown by Type
6.2.1 North America Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
6.2.2 North America Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
6.3 North America Antimicrobial Peptides Sales Breakdown by Application
6.3.1 North America Antimicrobial Peptides Sales Breakdown by Application (2016-2021)
6.3.2 North America Antimicrobial Peptides Sales Breakdown by Application (2022-2027)
7 Europe Antimicrobial Peptides Market Facts & Figures
7.1 Europe Antimicrobial Peptides Sales by Company
7.1.1 Europe Antimicrobial Peptides Sales by Company (2016-2021)
7.1.2 Europe Antimicrobial Peptides Revenue by Company (2016-2021)
7.2 Europe Antimicrobial Peptides Sales Breakdown by Type
7.2.1 Europe Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
7.2.2 Europe Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
7.3 Europe Antimicrobial Peptides Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)
8 China Antimicrobial Peptides Market Facts & Figures
8.1 China Antimicrobial Peptides Sales by Company
8.1.1 China Antimicrobial Peptides Sales by Company (2016-2021)
8.1.2 China Antimicrobial Peptides Revenue by Company (2016-2021)
8.2 China Antimicrobial Peptides Sales Breakdown by Type
8.2.1 China Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
8.2.2 China Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
8.3 China Antimicrobial Peptides Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Antimicrobial Peptides Market Facts & Figures
9.1 Japan Antimicrobial Peptides Sales by Company
9.1.1 Japan Antimicrobial Peptides Sales by Company (2016-2021)
9.1.2 Japan Antimicrobial Peptides Revenue by Company (2016-2021)
9.2 Japan Antimicrobial Peptides Sales Breakdown by Type
9.2.1 Japan Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
9.2.2 Japan Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
9.3 Japan Antimicrobial Peptides Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Antimicrobial Peptides Market Facts & Figures
10.1 Southeast Asia Antimicrobial Peptides Sales by Company
10.1.1 Southeast Asia Antimicrobial Peptides Sales by Company (2016-2021)
10.1.2 Southeast Asia Antimicrobial Peptides Revenue by Company (2016-2021)
10.2 Southeast Asia Antimicrobial Peptides Sales Breakdown by Type
10.2.1 Southeast Asia Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Antimicrobial Peptides Sales Breakdown by Application
10.3.1 Southeast Asia Mg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Mg Sales Breakdown by Application (2022-2027)
11 India Antimicrobial Peptides Market Facts & Figures
11.1 India Antimicrobial Peptides Sales by Company
11.1.1 India Antimicrobial Peptides Sales by Company (2016-2021)
11.1.2 India Antimicrobial Peptides Revenue by Company (2016-2021)
11.2 India Antimicrobial Peptides Sales Breakdown by Type
11.2.1 India Antimicrobial Peptides Sales Breakdown by Type (2016-2021)
11.2.2 India Antimicrobial Peptides Sales Breakdown by Type (2022-2027)
11.3 India Antimicrobial Peptides Sales Breakdown by Application
11.3.1 India Antimicrobial Peptides Sales Breakdown by Application (2016-2021)
11.3.2 India Antimicrobial Peptides Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Antimicrobial Peptides Business
12.1 AnaSpec
12.1.1 AnaSpec Corporation Information
12.1.2 AnaSpec Business Overview
12.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AnaSpec Antimicrobial Peptides Products Offered
12.1.5 AnaSpec Recent Development
12.2 AMP Biotech
12.2.1 AMP Biotech Corporation Information
12.2.2 AMP Biotech Business Overview
12.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AMP Biotech Antimicrobial Peptides Products Offered
12.2.5 AMP Biotech Recent Development
12.3 Phoenix Biotech
12.3.1 Phoenix Biotech Corporation Information
12.3.2 Phoenix Biotech Business Overview
12.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Phoenix Biotech Antimicrobial Peptides Products Offered
12.3.5 Phoenix Biotech Recent Development
12.4 Novabiotics
12.4.1 Novabiotics Corporation Information
12.4.2 Novabiotics Business Overview
12.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novabiotics Antimicrobial Peptides Products Offered
12.4.5 Novabiotics Recent Development
12.5 Chinese Peptide
12.5.1 Chinese Peptide Corporation Information
12.5.2 Chinese Peptide Business Overview
12.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Chinese Peptide Antimicrobial Peptides Products Offered
12.5.5 Chinese Peptide Recent Development
12.6 Ontores
12.6.1 Ontores Corporation Information
12.6.2 Ontores Business Overview
12.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ontores Antimicrobial Peptides Products Offered
12.6.5 Ontores Recent Development
12.7 GenScript
12.7.1 GenScript Corporation Information
12.7.2 GenScript Business Overview
12.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GenScript Antimicrobial Peptides Products Offered
12.7.5 GenScript Recent Development
12.8 Hycult Biotech
12.8.1 Hycult Biotech Corporation Information
12.8.2 Hycult Biotech Business Overview
12.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hycult Biotech Antimicrobial Peptides Products Offered
12.8.5 Hycult Biotech Recent Development
12.9 Sunsmile
12.9.1 Sunsmile Corporation Information
12.9.2 Sunsmile Business Overview
12.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Sunsmile Antimicrobial Peptides Products Offered
12.9.5 Sunsmile Recent Development
12.10 Ruixing Biotechnology
12.10.1 Ruixing Biotechnology Corporation Information
12.10.2 Ruixing Biotechnology Business Overview
12.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Ruixing Biotechnology Antimicrobial Peptides Products Offered
12.10.5 Ruixing Biotechnology Recent Development
12.11 Zhongnong Yingtai Biotechnology
12.11.1 Zhongnong Yingtai Biotechnology Corporation Information
12.11.2 Zhongnong Yingtai Biotechnology Business Overview
12.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Products Offered
12.11.5 Zhongnong Yingtai Biotechnology Recent Development
12.12 Glam Technology
12.12.1 Glam Technology Corporation Information
12.12.2 Glam Technology Business Overview
12.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Glam Technology Antimicrobial Peptides Products Offered
12.12.5 Glam Technology Recent Development
12.13 ProteLight Pharmaceutical & Biotechnology
12.13.1 ProteLight Pharmaceutical & Biotechnology Corporation Information
12.13.2 ProteLight Pharmaceutical & Biotechnology Business Overview
12.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2016-2021)
12.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Products Offered
12.13.5 ProteLight Pharmaceutical & Biotechnology Recent Development
13 Antimicrobial Peptides Manufacturing Cost Analysis
13.1 Antimicrobial Peptides Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antimicrobial Peptides
13.4 Antimicrobial Peptides Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antimicrobial Peptides Distributors List
14.3 Antimicrobial Peptides Customers
15 Market Dynamics
15.1 Antimicrobial Peptides Market Trends
15.2 Antimicrobial Peptides Drivers
15.3 Antimicrobial Peptides Market Challenges
15.4 Antimicrobial Peptides Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antimicrobial Peptides Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Antimicrobial Peptides Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Antimicrobial Peptides Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Antimicrobial Peptides Sales (Mg) by Region (2016-2021)
Table 5. Global Antimicrobial Peptides Sales Market Share by Region (2016-2021)
Table 6. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Antimicrobial Peptides Revenue Share by Region (2016-2021)
Table 8. Global Antimicrobial Peptides Sales (Mg) Forecast by Region (2022-2027)
Table 9. Global Antimicrobial Peptides Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Antimicrobial Peptides Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Antimicrobial Peptides Revenue Share Forecast by Region (2022-2027)
Table 12. Global Antimicrobial Peptides Sales (Mg) of Key Companies (2016-2021)
Table 13. Global Antimicrobial Peptides Sales Share by Company (2016-2021)
Table 14. Global Antimicrobial Peptides Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Antimicrobial Peptides Revenue Share by Company (2016-2021)
Table 16. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antimicrobial Peptides as of 2020)
Table 17. Global Antimicrobial Peptides Average Price (US$/Mg) of Key Company (2016-2021)
Table 18. Manufacturers Antimicrobial Peptides Manufacturing Sites and Area Served
Table 19. Manufacturers Antimicrobial Peptides Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Antimicrobial Peptides Sales (Mg) by Type (2016-2021)
Table 22. Global Antimicrobial Peptides Sales Share by Type (2016-2021)
Table 23. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Antimicrobial Peptides Price (US$/Mg) by Type (2016-2021)
Table 25. Global Antimicrobial Peptides Sales Share by Type (2022-2027)
Table 26. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Antimicrobial Peptides Revenue Share by Type (2022-2027)
Table 28. Global Antimicrobial Peptides Price (US$/Mg) by Type (2022-2027)
Table 29. Global Antimicrobial Peptides Sales (Mg) by Application (2016-2021)
Table 30. Global Antimicrobial Peptides Sales Share by Application (2016-2021)
Table 31. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Antimicrobial Peptides Price (US$/Mg) by Application (2016-2021)
Table 33. Global Antimicrobial Peptides Sales (Mg) by Application (2022-2027)
Table 34. Global Antimicrobial Peptides Sales Share by Application (2022-2027)
Table 35. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Antimicrobial Peptides Revenue Share by Application (2022-2027)
Table 37. Global Antimicrobial Peptides Price (US$/Mg) by Application (2022-2027)
Table 38. North America Antimicrobial Peptides Sales (Mg) by Company (2016-2021)
Table 39. North America Antimicrobial Peptides Sales Market Share by Company (2016-2021)
Table 40. North America Antimicrobial Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Antimicrobial Peptides Revenue Market Share by Company (2016-2021)
Table 42. North America Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
Table 43. North America Antimicrobial Peptides Sales Market Share by Type (2016-2021)
Table 44. North America Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
Table 45. North America Antimicrobial Peptides Sales Market Share by Type (2022-2027)
Table 46. North America Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
Table 47. North America Antimicrobial Peptides Sales Market Share by Application (2016-2021)
Table 48. North America Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
Table 49. North America Antimicrobial Peptides Sales Market Share by Application (2022-2027)
Table 50. Europe Antimicrobial Peptides Sales (Mg) by Company (2016-2021)
Table 51. Europe Antimicrobial Peptides Sales Market Share by Company (2016-2021)
Table 52. Europe Antimicrobial Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Antimicrobial Peptides Revenue Market Share by Company (2016-2021)
Table 54. Europe Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
Table 55. Europe Antimicrobial Peptides Sales Market Share by Type (2016-2021)
Table 56. Europe Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
Table 57. Europe Antimicrobial Peptides Sales Market Share by Type (2022-2027)
Table 58. Europe Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
Table 59. Europe Antimicrobial Peptides Sales Market Share by Application (2016-2021)
Table 60. Europe Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
Table 61. Europe Antimicrobial Peptides Sales Market Share by Application (2022-2027)
Table 62. China Antimicrobial Peptides Sales (Mg) by Company (2016-2021)
Table 63. China Antimicrobial Peptides Sales Market Share by Company (2016-2021)
Table 64. China Antimicrobial Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Antimicrobial Peptides Revenue Market Share by Company (2016-2021)
Table 66. China Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
Table 67. China Antimicrobial Peptides Sales Market Share by Type (2016-2021)
Table 68. China Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
Table 69. China Antimicrobial Peptides Sales Market Share by Type (2022-2027)
Table 70. China Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
Table 71. China Antimicrobial Peptides Sales Market Share by Application (2016-2021)
Table 72. China Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
Table 73. China Antimicrobial Peptides Sales Market Share by Application (2022-2027)
Table 74. Japan Antimicrobial Peptides Sales (Mg) by Company (2016-2021)
Table 75. Japan Antimicrobial Peptides Sales Market Share by Company (2016-2021)
Table 76. Japan Antimicrobial Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Antimicrobial Peptides Revenue Market Share by Company (2016-2021)
Table 78. Japan Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
Table 79. Japan Antimicrobial Peptides Sales Market Share by Type (2016-2021)
Table 80. Japan Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
Table 81. Japan Antimicrobial Peptides Sales Market Share by Type (2022-2027)
Table 82. Japan Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
Table 83. Japan Antimicrobial Peptides Sales Market Share by Application (2016-2021)
Table 84. Japan Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
Table 85. Japan Antimicrobial Peptides Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Antimicrobial Peptides Sales (Mg) by Company (2016-2021)
Table 87. Southeast Asia Antimicrobial Peptides Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Antimicrobial Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Antimicrobial Peptides Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
Table 91. Southeast Asia Antimicrobial Peptides Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
Table 93. Southeast Asia Antimicrobial Peptides Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
Table 95. Southeast Asia Antimicrobial Peptides Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
Table 97. Southeast Asia Antimicrobial Peptides Sales Market Share by Application (2022-2027)
Table 98. India Antimicrobial Peptides Sales (Mg) by Company (2016-2021)
Table 99. India Antimicrobial Peptides Sales Market Share by Company (2016-2021)
Table 100. India Antimicrobial Peptides Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Antimicrobial Peptides Revenue Market Share by Company (2016-2021)
Table 102. India Antimicrobial Peptides Sales by Type (2016-2021) & (Mg)
Table 103. India Antimicrobial Peptides Sales Market Share by Type (2016-2021)
Table 104. India Antimicrobial Peptides Sales by Type (2022-2027) & (Mg)
Table 105. India Antimicrobial Peptides Sales Market Share by Type (2022-2027)
Table 106. India Antimicrobial Peptides Sales by Application (2016-2021) & (Mg)
Table 107. India Antimicrobial Peptides Sales Market Share by Application (2016-2021)
Table 108. India Antimicrobial Peptides Sales by Application (2022-2027) & (Mg)
Table 109. India Antimicrobial Peptides Sales Market Share by Application (2022-2027)
Table 110. AnaSpec Corporation Information
Table 111. AnaSpec Description and Business Overview
Table 112. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 113. AnaSpec Antimicrobial Peptides Product
Table 114. AnaSpec Recent Development
Table 115. AMP Biotech Corporation Information
Table 116. AMP Biotech Description and Business Overview
Table 117. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 118. AMP Biotech Antimicrobial Peptides Product
Table 119. AMP Biotech Recent Development
Table 120. Phoenix Biotech Corporation Information
Table 121. Phoenix Biotech Description and Business Overview
Table 122. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 123. Phoenix Biotech Antimicrobial Peptides Product
Table 124. Phoenix Biotech Recent Development
Table 125. Novabiotics Corporation Information
Table 126. Novabiotics Description and Business Overview
Table 127. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 128. Novabiotics Antimicrobial Peptides Product
Table 129. Novabiotics Recent Development
Table 130. Chinese Peptide Corporation Information
Table 131. Chinese Peptide Description and Business Overview
Table 132. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 133. Chinese Peptide Antimicrobial Peptides Product
Table 134. Chinese Peptide Recent Development
Table 135. Ontores Corporation Information
Table 136. Ontores Description and Business Overview
Table 137. Ontores Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 138. Ontores Antimicrobial Peptides Product
Table 139. Ontores Recent Development
Table 140. GenScript Corporation Information
Table 141. GenScript Description and Business Overview
Table 142. GenScript Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 143. GenScript Antimicrobial Peptides Product
Table 144. GenScript Recent Development
Table 145. Hycult Biotech Corporation Information
Table 146. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 147. Hycult Biotech Description and Business Overview
Table 148. Hycult Biotech Antimicrobial Peptides Product
Table 149. Hycult Biotech Recent Development
Table 150. Sunsmile Corporation Information
Table 151. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 152. Sunsmile Description and Business Overview
Table 153. Sunsmile Antimicrobial Peptides Product
Table 154. Sunsmile Recent Development
Table 155. Ruixing Biotechnology Corporation Information
Table 156. Ruixing Biotechnology Description and Business Overview
Table 157. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 158. Ruixing Biotechnology Antimicrobial Peptides Product
Table 159. Ruixing Biotechnology Recent Development
Table 160. Zhongnong Yingtai Biotechnology Corporation Information
Table 161. Zhongnong Yingtai Biotechnology Description and Business Overview
Table 162. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 163. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 164. Zhongnong Yingtai Biotechnology Recent Development
Table 165. Glam Technology Corporation Information
Table 166. Glam Technology Description and Business Overview
Table 167. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 168. Glam Technology Antimicrobial Peptides Product
Table 169. Glam Technology Recent Development
Table 170. ProteLight Pharmaceutical & Biotechnology Corporation Information
Table 171. ProteLight Pharmaceutical & Biotechnology Description and Business Overview
Table 172. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (Million USD), Price (US$/Mg) and Gross Margin (2016-2021)
Table 173. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
Table 174. ProteLight Pharmaceutical & Biotechnology Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Antimicrobial Peptides Distributors List
Table 178. Antimicrobial Peptides Customers List
Table 179. Antimicrobial Peptides Market Trends
Table 180. Antimicrobial Peptides Market Drivers
Table 181. Antimicrobial Peptides Market Challenges
Table 182. Antimicrobial Peptides Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Antimicrobial Peptides Product Picture
Figure 2. Global Antimicrobial Peptides Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antimicrobial Peptides Sales Market Share by Application in 2021 & 2027
Figure 6. Pharmaceuticals Examples
Figure 7. Feed Additives Examples
Figure 8. Others Examples
Figure 9. Global Antimicrobial Peptides Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Antimicrobial Peptides Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Antimicrobial Peptides Sales (Mg) Growth Rate (2016-2027)
Figure 12. Global Antimicrobial Peptides Price Trends Growth Rate (2016-2027) (US$/Mg)
Figure 13. Global Antimicrobial Peptides Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Antimicrobial Peptides Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Antimicrobial Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Antimicrobial Peptides Sales (Mg) Growth Rate (2016-2027)
Figure 17. Europe Antimicrobial Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Antimicrobial Peptides Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Antimicrobial Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Antimicrobial Peptides Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Antimicrobial Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Antimicrobial Peptides Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Antimicrobial Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Antimicrobial Peptides Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Antimicrobial Peptides Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Antimicrobial Peptides Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Antimicrobial Peptides Players Market Share by Revenue in Antimicrobial Peptides: 2016 & 2020
Figure 28. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Antimicrobial Peptides Revenue Share by Type (2016-2021)
Figure 30. Global Antimicrobial Peptides Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Antimicrobial Peptides Revenue Share by Application (2016-2021)
Figure 32. Global Antimicrobial Peptides Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Antimicrobial Peptides Sales Market Share by Type in 2020
Figure 34. North America Antimicrobial Peptides Sales Market Share by Application in 2020
Figure 35. Europe Antimicrobial Peptides Sales Market Share by Type in 2020
Figure 36. Europe Antimicrobial Peptides Sales Market Share by Application in 2020
Figure 37. China Antimicrobial Peptides Sales Market Share by Type in 2020
Figure 38. China Antimicrobial Peptides Sales Market Share by Application in 2020
Figure 39. Japan Antimicrobial Peptides Sales Market Share by Type in 2020
Figure 40. Japan Antimicrobial Peptides Sales Market Share by Application in 2020
Figure 41. Southeast Asia Antimicrobial Peptides Sales Market Share by Type in 2020
Figure 42. Southeast Asia Antimicrobial Peptides Sales Market Share by Application in 2020
Figure 43. India Antimicrobial Peptides Sales Market Share by Type in 2020
Figure 44. India Antimicrobial Peptides Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Antimicrobial Peptides
Figure 47. Manufacturing Process Analysis of Antimicrobial Peptides
Figure 48. Antimicrobial Peptides Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed